Introduction
============

Renovascular hypertension resulting from renal artery stenosis is an important cause of secondary hypertension that is often related to the activation of the renin-angiotensin system (RAS), leading to problems in many organs, including cardiac insufficiency ([@b1-mmr-20-05-4467]). This condition, which affects 5% of patients suffering from systemic arterial hypertension, can be caused by atherosclerosis and is associated with cardiovascular disease ([@b2-mmr-20-05-4467]). In the same way, poor renal function in cases of renovascular hypertension is associated with an increase in oxidative stress and markers of renal damage, indicated by inflammation and fibrosis ([@b3-mmr-20-05-4467]). Inflammation and oxidative stress have synergistic effects on the pathophysiology of arterial hypertension and cardiovascular remodeling ([@b4-mmr-20-05-4467]). Oxidative stress resulting from the imbalance between the production and degradation of reactive oxygen species (ROS) is one of the main causes of endothelial dysfunction, due to the decreased bioavailability of nitric oxide to react with superoxide anions, resulting in the formation of peroxynitrite ([@b5-mmr-20-05-4467]).

Epithelial-to-mesenchymal transition (EMT) and endothelial-to-mesenchymal transition (EndMT) are complex and dynamic processes that are important for normal wound healing, but are deleterious in fibrogenic diseases, including hepatic, cardiac and renal fibrosis ([@b6-mmr-20-05-4467]--[@b8-mmr-20-05-4467]). During EMT/EndMT, epithelial/endothelial cells modify their phenotype and express markers of mesenchymal cells, with leads to an alteration of their functions; for example, the acquisition of the ability to migrate and synthesize interstitial matrix ([@b9-mmr-20-05-4467]). Members of the cadherin family of transmembrane glycoproteins, including E-cadherin (E-cad) and N-cadherin (N-cad), represent the main components of adherens junctions (AJs), and are mediators of Ca^2+^-dependent adhesion between cells and promote intercellular binding to the actin of the cytoskeleton ([@b10-mmr-20-05-4467]). E-cad and N-cad are very similar in terms of sequence and structure, but demonstrate highly specific cell adhesion behavior ([@b11-mmr-20-05-4467]). E-cad acts in the maintenance of epithelium integrity ([@b12-mmr-20-05-4467]), while N-cad is known to be a mediator of the connections between fibroblasts ([@b13-mmr-20-05-4467]). The EMT process requires the inhibition of several genes encoding proteins responsible for cell adhesion, such as E-cad. However, there is an upregulation of genes encoding cytoskeletal proteins, such as N-cad and α-smooth muscle actin (α-SMA), that undergo intracellular rearrangements, allowing stroma invasion. In addition, there is an upregulation of extracellular matrix-associated proteins, such as fibronectin, collagen I/III and metalloproteinases ([@b14-mmr-20-05-4467]).

There have been several previous studies concerning EMT in cancer ([@b15-mmr-20-05-4467],[@b16-mmr-20-05-4467]) and repair following damage ([@b17-mmr-20-05-4467],[@b18-mmr-20-05-4467]). However, little is known about the role of AJs, mediated by proteins such as E-cad and N-cad, or the transdifferentiation of epithelial/endothelial and mesenchymal markers in cases of renovascular hypertension. Thus, it was hypothesized that epithelial/endothelial and mesenchymal markers are differentially regulated by hypertension in different tissues. In the present study, the effect of renovascular hypertension on the gene expression of epithelial/endothelial and mesenchymal markers was investigated, following inflammatory processes and oxidative stress in the liver, kidneys and cardiac muscle.

Materials and methods
=====================

### Ethics declaration and animal care

All the surgical and experimental procedures carried out in the present study complied with the Care and Use of Laboratory Animals standards established by the National Institute of Health (NIH Publication 80--23, revised in 2011). The present study was carried out in accordance with Brazilian legal requirements (federal law 11794/2008) and were approved by the Animal Use Ethics Committee of the University Center of the Hermínio Ometto Foundation (protocol no. 036/2014). The work complied with the animal experimentation ethical standards of the Brazilian College of Animal Experimentation. The experiments used 18 male Wistar rats (age, 50 days) weighing 180--200 g obtained from the Animal Experimentation Center of the Hermínio Ometto Foundation. The animals were housed in cages (2--3 rats/cage) at a controlled temperature of 21--23°C and humidity of 60%, with a 12 h light/dark cycle and free access to water and feed.

### Experimental groups and induction of hypertension

The animals were randomly divided into two experimental groups and were anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). The left kidney was exposed using a small incision in the flank and the renal artery was dissected from the renal vein and the adjacent tissues. In 11 animals, a U-shaped silver clip with an internal diameter of 0.2 mm was placed around the renal artery \[according to the 2-kidney, 1-clip (2K1C) model of renin-dependent hypertension\], resulting in stenosis of the artery, as described by Goldblatt *et al* ([@b19-mmr-20-05-4467]). The sham animals (n=7) underwent the same surgical procedure, but without insertion of the clip. After 4 weeks of hypertension induction, the animals were euthanized by deep anesthesia (100 mg/kg ketamine and 10 mg/kg xylazine) and the liver, heart and kidneys were removed.

### Monitoring of systolic blood pressure and body weight

The systolic blood pressure was measured by the noninvasive method of tail plethysmography. Cuffs coupled to pressure transducers were placed around the tails of the awake animals, which had been previously warmed in a cabinet at 37°C. The pressure change data were acquired using a Power Lab 4/S analog-to-digital converter (ADInstruments Pty Ltd.) and the results were presented as the average of three consecutive measurements for each animal. Prior to the first arterial pressure measurement, the animals were adapted to the procedure by placing them in the acrylic container on 5 consecutive days. The arterial pressure and body weight were determined on a weekly basis during the 4 weeks of the study. The model was deemed to have been successfully established if the systolic blood pressure was higher than 160 mmHg after 4 weeks of operation.

### Morphometry and stereology

Representative areas of the hepatic tissue, left cardiac ventricle and renal cortex were imaged using a Leica DM2000 light microscope (magnification, ×400). The samples were fixed in formaline 10% for 48 h at room temperature. Samples were embedded in Paraplast^®^ (Sigma-Aldrich; Merck KGaA) and dehydrated using increasing alcohol series. This was followed by morphometric and stereological analyses performed with Image-Pro Plus^®^ v.4.5.0.29 software (Media Cybernetics, Inc.). The analyses used 5 µm histological sections, with spacings between the sections of 40 µm (liver and heart) and 20 µm (kidney). The histological sections were treated at 37°C using a combined histochemical technique employing 1% Alcian Blue (pH 2.5) with 0.5% Periodic Acid with Schiff Reagent (AB + PAS) for 15, 5 and 10 min, respectively, or using a traditional Mallory\'s trichrome (MT) staining solution at 37°C for 35 min.

Stereological analysis of the liver was performed using the previous samples treated with AB + PAS and imaged using a Leica DM2000 light microscope (magnification, ×400). A grid of 475 intersections was selected for each of 10 images, totaling 4,750 intersections per animal, in order to determine the frequencies of interstitial and cellular components, and the corresponding areas occupied. The interstitial components observed were the connective tissue and the blood vessels, while the cellular components were the hepatocyte cytoplasm and the mono- or binucleate nucleus of these cells. The total number of hepatocytes was counted in 10 fields of view, with a morphometric assessment of the area of these cells also carried out.

Evaluation of the cardiac tissue employed samples stained with MT and imaged at ×400 magnification. The analysis involved the determination of the number of cardiomyocytes and the area occupied, considering cells in the transversal plane occupying the entire image in question, as well as the percentage of the area occupied by collagen fibers in regions with a predominance of fibers cut in the longitudinal plane. This evaluation used 10 images, each with a grid with 540 intersections, totaling 5,400 intersections per animal. This procedure enabled the determination of the frequency of areas with connective tissue associated with the cardiac cells.

The morphometric analyses of the right and left renal cortex were used to determine the corpuscle and glomerular capillary diameters, considering 10 glomeruli. For this, samples subjected to the AB + PAS histochemical procedure were photo-documented at ×400 magnification. The stereological analysis used samples stained with MT and photo-documented at 400× magnification. A grid with 690 intersections was applied to each of 10 images of the renal cortex, totaling 6,900 intersections per animal, in order to determine the proportions of the kidney components (blood vessels, connective tissue, glomerular corpuscles and tubular epithelium and lumen).

### ELISA

Total proteins were extracted from hepatic, cardiac and renal tissues samples using a detergent-based extraction buffer (T-PER Tissue Protein Extraction Reagent; Thermo Fisher Scientific, Inc.) containing a protease inhibitor cocktail (Roche Diagnostics). The tissue samples were macerated in buffer \[1:20 (w/v) of tissue to T-PER Reagent\], centrifuged at 1,200 × g for 10 min at 4°C and the supernatant was collected. The total protein present in each sample was quantified using the Bradford assay. The levels of interleukin (IL)-4, IL-6, IL-10, tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) were determined using Rat Platinum ELISA kits (cat. nos. 5018354, 13467093, 15532067, 13427093 and 15512057, respectively; eBioscience; Thermo Fisher Scientific, Inc.), according to the manufacturer\'s instructions. Standard curves were constructed for the cytokine protein concentration (pg/ml) plotted against the mean optical density for the replicates. The concentrations of the cytokines in the samples (in duplicate) were determined using the standard curves.

### Evaluation of the redox state

Lipid peroxidation was evaluated by quantification of the levels of thiobarbituric acid reactive substances (TBARS) in hepatic, cardiac and renal tissue homogenates, as described previously ([@b20-mmr-20-05-4467]). The reduced thiols (-SH groups) of proteins were determined using 5.5′-dithiobis-(2-nitrobenzoic acid), as described by Faure and Lafond ([@b21-mmr-20-05-4467]).

### Determination of mRNA expression by reverse transcription (RT)-PCR

Total RNA was extracted from the liver, left cardiac ventricle and kidneys of the sham and 2K1C animals using TRIzol^®^ reagent (Invitrogen; Thermo Fisher Scientific, Inc.), followed by quantification using UV spectrophotometry at a wavelength of 260 nm. The quality was evaluated using 1% agarose gel electrophoresis. Generation of cDNA was performed using RT with 2 µg/µl total RNA with random primers (150 ng/µl), dNTPs (10 mmol/µl) and the SuperScript II Reverse Transcriptase kit at 25°C for 10 min, followed by an incubation at 42°C for 50 min and at 70°C for 15 min (Invitrogen; Thermo Fisher Scientific, Inc.) in a final volume of 20 µl, according of the manufacturer\'s protocol. mRNA expression was determined by semiquantitative RT-PCR using a PCR thermocycler (AmpliTherm) in a final volume of 25 µl containing 1 µl cDNA, 10X PCR buffer (10 mM Tris-HCL; pH 8.8) (Invitrogen; Thermo Fisher Scientific, Inc.), 200--400 mM of each dNTP, 0.2 pmol of each primer, 1.6--2.0 mM MgCl~2~, and 0.04 U Taq DNA polymerase (Invitrogen; Thermo Fisher Scientific, Inc.). The primers specific for each gene used for PCR were: E-cad, forward (F) 5′-GCAGTTCTGCCAGAGAAACC-3′ and reverse (R) 5′-AATCCTGCTTCCAGGGAGAT-3′; N-cad, F 5′-TGTTGCTGAAGAAAACCAAG-3′ and R 5′-GGCGACTCTCTGTCCAGAAC-3′; α-SMA, F 5′-CACCATCGGGAATGAACGCT-3′ and R 5′-CGAGAGGACGTTGTTAGCATAGAG-3′; collagen I (COL1A1), F 5′-GGAAGCTTGGTCCTCTTGCT-3′ and R 5′-GTTAGGCTCCTTCAATAGTCC-3′; collagen III (COL3A1), F 5′-AGGCCAATGGCAATGTAAAG-3′ and R 5′-CAATGTCATAGGGTGCGATA-3′; hepatocyte growth factor (HGF), F 5′-TTCCCAGCTAGTCTATGGAC-3′ and R 5′-TGGTGCTGACTGCATTTCTC-3′; and β-actin, F 5′-AGAGGGAAATCGTGCGTGACA-3′ and R 5′-CGATAGTGATGACCTGACCGTCA-3′. The amplification conditions were as follows: Initial denaturation at 93°C for 3 min, followed by 26 cycles for the β-actin gene, 30 cycles for E-cad, N-cad and COL3A1, 32 cycles for α-SMA, and 34 cycles for COL1A1 and HGF. The cycles consisted of a denaturation step at 94°C for 30 sec (β -actin, E-cad, N-cad, COL1A1 and COL3A1) or 1 min (α-SMA and HGF); annealing at 55°C for 30 sec (E-cad, N-cad, COL1A1 and COL3A1), at 57°C for 30 sec (β-actin), or at 59°C for 1 min (α-SMA and HGF); extension at 72°C for 30 sec (β-actin, E-cad, N-cad, COL1A1 and COL3A1) or 1 min (α-SMA and HGF). The PCR products were separated by 1.5% agarose gel electrophoresis and were stained with ethidium bromide. The gel was imaged using the Syngen G:Box^®^ system, followed by densitometric quantification of the bands using Scion Image 4.0 software (Scion Corporation). The relative expression of the genes investigated were obtained by normalization with the expression values obtained for the β-actin gene.

### Statistical analysis

The data are presented as the mean ± SEM, considering the results of three independent experiments. Differences between groups were evaluated using the unpaired Student\'s t-test and one-way ANOVA followed by the Bonferroni post-hoc test. Statistical analyses were performed using GraphPad Prism v. 5.0 software (GraphPad Software, Inc.). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Biometric and morphometric analyses

[Table I](#tI-mmr-20-05-4467){ref-type="table"} details the characteristics of the sham and 2K1C groups as assessed on the day of the experiment. Compared with the sham group, the 2K1C animals subjected to the clipping of the renal artery exhibited higher systolic arterial pressure (203±9 vs. 148±4 mmHg in sham; P=0.0003), increased heart weight (1.39±0.09 vs. 1.005±0.09 g in sham, P=0.01) and right kidney weight (1.63±0.13 vs. 1.25±0.07 g in sham, P=0.04; [Table I](#tI-mmr-20-05-4467){ref-type="table"}). The body and liver weights were similar for the two groups. Histological analysis showed that the 2K1C animals had a normal hepatic cytoarchitecture, without any changes in the hepatocyte number or area. The areas occupied by connective tissue, blood vessels, and mono- and binucleate nuclei were similar for all the animals ([Fig. 1A-D](#f1-mmr-20-05-4467){ref-type="fig"}).

Hypertension led to cardiac hypertrophy, as shown by a 29% increase in the heart weight index ([Table I](#tI-mmr-20-05-4467){ref-type="table"}), and was associated with a decrease in the number of cardiomyocytes (1,894±114.7 vs. 3,107±357.1 in sham, P=0.005; [Fig. 1E and G](#f1-mmr-20-05-4467){ref-type="fig"}) and an increase in their area (292.9±30.54 vs. 181.6±35.43 *µm*^2^ in sham, P=0.04; [Fig. 1E and F](#f1-mmr-20-05-4467){ref-type="fig"}) in the animals in the 2K1C group. This was accompanied by an increase in the area occupied by collagen fibers in the cardiac tissue of the 2K1C animals compared with the sham group (2.90±0.12 vs. 1.80±0.30%/10^4^ *µm*^2^, respectively, P=0.004; [Fig. 1E and H](#f1-mmr-20-05-4467){ref-type="fig"}).

By contrast, the weight value of the left kidney in the 2K1C animals (0.93±0.07 g) was lower in comparison to the contralateral kidney (1.63±0.13 g, P=0.0001) and the sham group (1.28±0.11 g, P=0.012; [Table I](#tI-mmr-20-05-4467){ref-type="table"}). The left kidney/right kidney ratio was lower in the 2K1C animals than in the sham group ([Table I](#tI-mmr-20-05-4467){ref-type="table"}). Renovascular hypertension also led to fibrotic changes in the stenotic kidney, as shown by the greater area of the renal cortex occupied by connective tissue (22.98±3.33%) compared with the sham group (10.32±0.37%; P=0.01; [Fig. 1I and J](#f1-mmr-20-05-4467){ref-type="fig"}). This was supported by a decrease of the area occupied by epithelium in the 2K1C animals (55.62±3.5 vs. 74.29±1.3%, P=0.003; [Fig. 1I and J](#f1-mmr-20-05-4467){ref-type="fig"}). No differences between the groups were observed for the remaining parameters determined for both kidneys ([Fig. 1J and K](#f1-mmr-20-05-4467){ref-type="fig"}).

### Inflammatory and fibroproliferative profiles

The 2K1C group showed increases in the levels of the inflammatory cytokine TNF-α in the liver (1,114.5±99.6 vs. 813.9±52; P=0.04) and IL-6 in the stenotic kidney (9,896.9±252 vs. 8,333.1±267; P=0.004) compared with the sham group ([Table II](#tII-mmr-20-05-4467){ref-type="table"}). No differences between the groups were observed for the anti-inflammatory cytokines IL-4 and IL-10 in the liver, heart and kidneys. However, there were increases in the levels of the fibroproliferative cytokine TGF-β1 in the liver, heart and stenotic kidney in the 2K1C group (599.4±80.3 vs. 353.6±42.9, P=0.04; 115.0±4 vs. 89.05±4, P=0.004; 631.2±42 vs. 438.6±40, P=0.01; respectively; [Table II](#tII-mmr-20-05-4467){ref-type="table"}).

### Redox and antioxidant status

The levels of TBARS, an indicator of lipid peroxidation, were higher in the right (0.021±0.002) and left kidneys (0.022±0.004) of the 2K1C animals compared with the sham group (0.017±0.001 and 0.012±0.003, respectively; P=0.01; [Table III](#tIII-mmr-20-05-4467){ref-type="table"}). No differences between the experimental groups were observed for this parameter in the liver and heart. The level of -SH groups, indicative of antioxidant capacity, was only increased in the heart of the 2K1C animals (1.376±0.208) compared with the sham group (0.996±0.118, P=0.01; [Table III](#tIII-mmr-20-05-4467){ref-type="table"}).

### Effect of renovascular hypertension on the mRNA expression of genes involved in fibrosis and EMT/EndMT

The hepatic mRNA expressions of the E-cad, N-cad, COL1A1, COL3A1, α-SMA and HGF were not affected by hypertension ([Fig. 2A](#f2-mmr-20-05-4467){ref-type="fig"}). The hearts of the 2K1C animals showed increased mRNA expression of the E-cad (0.69±0.08), N-cad (0.73±0.02), α-SMA (1.11±0.09), COL1A1 (1.66±0.18) and HGF (0.56±0.02) compared with the sham group (E-cad, 0.2±0.02, P=0.0001; N-cad, 0.49±0.04, P=0.0001; α-SMA, 0.72±0.13, P=0.02; COL1A1, 0.93±0.2, P=0.02; HGF, 0.38±0.03, P=0.0003). No significant change in the expression of the COL3A1 gene was observed ([Fig. 2B](#f2-mmr-20-05-4467){ref-type="fig"}). Hypertension decreased the renal mRNA expression of the E-cad gene (Right-2K1C 0.85±0.06 vs. sham 1.14±0.03, P=0.002; Left-2K1C 0.85±0.06 vs. sham 1.25±0.08, P=0.001) and increased expression of the α-SMA (Right-2K1C 1.69±0.19 vs. sham 1.03±0.03, P=0.01; Left-2K1C 1.63±0.13 vs. sham 1.00±0.06, P=0.002). However, increased expression of the N-cad (2K1C 1.17±0.08 vs. sham 0.82±0.05, P=0.006) and COL1A1 (2K1C 3.41±0.39 vs. sham 1.96±0.32, P=0.02), and the decreased expression of the COL3A1 gene (2K1C 0.89±0.08 vs. sham 1.63±0.28, P=0.008) was only observed in the left stenotic kidney. The 2K1C group presented differential regulation of HGF expression in the two kidneys ([Fig. 2C](#f2-mmr-20-05-4467){ref-type="fig"}). Hypertension increased the mRNA expression of HGF in the left kidney (2K1C 0.94±0.03 vs. sham 0.77±0.07, P=0.02) but decreased the expression of this gene in the contralateral kidney (2K1C 0.58±0.05 vs. sham 0.82±0.09, P=0.02; [Fig. 2C](#f2-mmr-20-05-4467){ref-type="fig"}).

Discussion
==========

In the 2K1C renovascular hypertension model, there is a chronic decrease of the blood flow and consequently of the renal perfusion pressure, resulting in elevated plasma renin levels. This is associated with an increase in the level of angiotensin II, which in turn leads to increased arterial pressure ([@b22-mmr-20-05-4467]). In addition, prolonged exposure to angiotensin II contributes to the development of cardiovascular hypertrophy and remodeling ([@b23-mmr-20-05-4467]). Left renal artery clamping leads to a hypertrophic response in the myocardium. In the present study, clamping led to an increased cardiac mass and cardiomyocyte area observed for the 2K1C animals. Thus, hypertension caused the myocardium to adapt to the increased load, with this adaptive response eventually resulting in an increased cardiac mass ([@b24-mmr-20-05-4467]). The weight difference found between the clipped and non-clipped kidneys in the present study was also indicative of the effectiveness of the surgically induced experimental model. The findings of the present study suggested that the contralateral (non-clipped) kidney was able to prevent an increase in the blood volume and consequent additional increase in the arterial pressure. This is consistent with a previous study where a clip with a 0.2 mm aperture obstructed \>70% of the renal blood flow and led to renovascular hypertension ([@b25-mmr-20-05-4467]).

The increased production of the inflammatory factors TGF-β1, TNF-α and IL-6 in the different organs of the hypertensive animals was indicative of the existence of an inflammatory process ([@b26-mmr-20-05-4467]). Cardiovascular damage caused by excessive stimulation of the RAS and AT1 receptors (AT1R), induced by the 2K1C experimental model, is mediated through proinflammatory activation of the immune system ([@b27-mmr-20-05-4467]). Moreover, inflammatory cell recruitment is associated with the development of left ventricular fibrosis and remodeling in the hypertensive heart ([@b28-mmr-20-05-4467]), as demonstrated by the increase of connective tissue in the 2K1C animals of the present study. Similarly, increased renal inflammation is associated with greater tissue fibrosis and loss of renal function ([@b29-mmr-20-05-4467]), which is in agreement with the histological findings of the present study.

It is known that in addition to vasoconstriction, angiotensin II can induce oxidative stress due to the stimulation of AT1R by activation of the NADH/NADPH oxidase enzyme in vascular cells, increasing intracellular synthesis of ROS ([@b30-mmr-20-05-4467]). Thus, oxidative stress is associated with the activation of inflammatory processes ([@b31-mmr-20-05-4467]), this is consistent with the increased production of cytokines or growth factors found in the hypertensive rats in the present study. The results obtained in the present study demonstrated that hypertension led to increased oxidative stress in the kidneys, as indicated by the increase of TBARS. However, the activity of superoxide dismutase was not examined and is a limitation of the present study. Previous studies involving animal models of hypertension have shown that an abundance of ROS, due either to their increased production or their decreased degradation, determines the extent of oxidative damage in tissues ([@b32-mmr-20-05-4467]--[@b34-mmr-20-05-4467]). However, in the present study, no differences were observed in the levels of lipid peroxidation between the sham and 2K1C groups in the liver and heart, although an increased level of TGF-β1 was observed. Whereas elevated lipid peroxidation is associated with liver damage ([@b35-mmr-20-05-4467]), the results obtained in the liver in the present study supported the fact that a precise balance between the levels of ROS and the corresponding antioxidants is important for maintaining proper cellular functions ([@b36-mmr-20-05-4467]). In the heart, the levels of -SH groups were increased in an attempt to protect itself against oxidative damage. This is likely to be the reason that no alterations in the levels of TBARS were observed.

In addition to the inflammatory damage induced by hypertension, as shown by the increased levels of proinflammatory molecules, fibroblast markers and collagen deposition, it was also observed that epithelial and mesenchymal genes were differentially expressed in the kidneys, leading to the occurrence of EMT. This phenotype in the renal cells was observed as a reduction in the expression of E-cad and an increase of the mesenchymal/fibroblast markers such as N-cad, α-SMA and COL1A1. These changes were associated with the loss of tubular epithelial cells and increased amounts of connective tissue. Both increased proliferation of resident fibroblasts (and/or collagen) and epithelial cells undergoing EMT may be associated with the release of TGF-β1 ([@b37-mmr-20-05-4467]). Consistent with this hypothesis, the upregulated expression of N-cad and COL1A1 in only the clipped kidney can be explained by the increase of TGF-β1 and IL-6 in this organ. Moreover, while an increased level of COL1A1 expression was observed, the level of COL3A1 was reduced. This is indicative of the synthesis of collagen type III gradually being replaced by collagen type I in the early stages of renal fibrosis ([@b38-mmr-20-05-4467]). The transition of tubular epithelial cells into cells with mesenchymal features results in functional debility and an increased regenerative response, inducing an immunological reaction and recruitment of myofibroblasts ([@b39-mmr-20-05-4467]). The increased gene expression of α-SMA, as well as other data of the present study, supported these findings. Furthermore, there is evidence that oxidative stress is involved in the pathogenesis of TGF-β1-induced EMT through the activation of mitogen-activated protein kinase and Smad pathways ([@b40-mmr-20-05-4467]).

The HGF gene showed differential expression in the kidneys of the hypertensive animals. Therefore, increased mRNA expression of the HGF gene in the left kidney, together with its decreased expression in the contralateral kidney, was indicative of the stimulation of the transcriptional regulation of this gene in an attempt to counter the fibrotic action of TGF-β1. One of the activities of TGF-β1 is the negative regulation of the transcription of E-cad and other components of AJs, leading to the loss of epithelial intercellular adhesion, which is associated with cellular delamination from the epithelial layer ([@b41-mmr-20-05-4467]). This phenomenon was observed in the present study, with the decreased expression of E-cad transcripts in the kidneys being explained by the increased expression of TGF-β1. However, other factors may be involved in the negative regulation of E-cad expression, such as microRNA-214-3p, under hypoxic conditions ([@b42-mmr-20-05-4467]), as well as the zinc finger protein SNAI1 family of transcription factors during embryo development and tumor progression ([@b43-mmr-20-05-4467]). In another model of hypertension, the consumption of dietary salt induced renal fibrosis and tubular EMT, as identified by reduced E-cad expression and increased α-SMA expression ([@b44-mmr-20-05-4467]).

In the present study, the increased blood pressure led to an increase in the area occupied by collagen fibers in the cardiac tissue, which was associated with the increased expression of the COL1A1 gene, a marker of fibrosis. These findings were supported by the increased levels of the TGF-β1 profibrotic cytokine in the hypertensive animals, as well as by the increased expression of the N-cad and α-SMA mesenchymal markers. The increased expression of N-cadherin has been observed in animals with hypertrophic hearts ([@b45-mmr-20-05-4467]). The transformation of cardiac fibroblasts into myofibroblasts is predominantly promoted by TGF-β1 and other growth factors, resulting in the excessive production of extracellular matrix proteins ([@b7-mmr-20-05-4467]). In the process of cardiac fibrosis, the level of α-SMA increases during transdifferentiation of the fibroblasts into myofibroblasts ([@b46-mmr-20-05-4467]). The expression of E-cad was positively regulated by hypertension, consequently, the transdifferentiation from endothelial to mesenchymal phenotype was not observed, despite the high levels of TGF-β1 in the heart. Considering that the dynamic control of E-cad is fundamental in establishing and maintaining the junctions between epithelial cells ([@b47-mmr-20-05-4467]), the increased gene expression observed was suggestive of an attempt to restore cardiac function. This hypothesis was supported by the increased gene expression of HGF, which negatively regulates the transformation of cardiac fibroblasts in response to TGF-β1 ([@b48-mmr-20-05-4467],[@b49-mmr-20-05-4467]). On the other hand, partial EndMT may also occur ([@b39-mmr-20-05-4467]), in which cells exhibit both endothelial and mesenchymal markers and, therefore, have a hybrid phenotype ([@b50-mmr-20-05-4467],[@b51-mmr-20-05-4467]).

In the normal liver, the expression of TGF-β1 is low; however, higher expression occurs in the case of liver damage ([@b52-mmr-20-05-4467]). Despite the increased levels of the proinflammatory cytokines TGF-β1 and TNF-α in the liver of the hypertensive animals, the epithelial E-cad and the mesenchymal N-cad, α-SMA and COL1A1 gene transcripts were not modulated by hypertension. There were also no changes in the expression of the COL3A1 and HGF genes, or the cellular organization of the hepatic tissue. The data from the present study suggested that during the 28 day experimental period, renovascular hypertension did not cause damage to the liver tissue as there was no proliferation of hepatocytes or activation of hepatic stellate cells, which would lead to fibrosis ([@b53-mmr-20-05-4467]). Therefore, it is hypothesized that these results indicate that the hepatic antioxidant capacity stimulated a protective mechanism for the tissue. Thus, the epithelial/endothelial and mesenchymal genes expressed in the liver, heart and kidneys are differentially regulated by renovascular hypertension. Collectively, the data indicated that renovascular hypertension caused renal damage that stimulated the transcription of EMT/EndMT genes in the kidneys and the heart. However, in the heart, these genes were differentially modulated, which may occur to maintain cardiac function.
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![Histology pattern, morphometry and stereology results. (A) Liver sections stained with AB + PAS show similar structures in both the sham and 2K1C groups, with the liver morphometry and stereology results exhibiting no statistical differences between the groups in terms of (B) the hepatocyte area, (C) the number of hepatocyte per unit of area and (D) stereology. (E) Heart sections stained with MT, arrows indicate connective tissue; the 2K1C group showed an increase in (F) cardiomyocyte area combined with a reduction in the (G) frequency of cardiomyocytes per unit area. (H) In accordance with this pattern, an increased area occupied by connective tissue was observed. (I) R and L kidneys stained with AB + PAS and MT. (I) The 2K1C group showed more area occupied by connective tissue (as indicated by the arrow) and less area occupied by (J) tubular epithelium. (K) There were no differences in glomerular morphometry between the groups. Blue areas in MT stained samples indicates areas with collagen fibers, indicative of connective tissue. Scale bar, 50 µm. \*P\<0.05 vs. sham. AB + PAS, Alcian Blue (pH 2.5) with Periodic Acid-Schiff; 2K1C, 2 kidney 1 clip; R, right; L, left; MT, Mallory\'s trichrome.](MMR-20-05-4467-g00){#f1-mmr-20-05-4467}

![Effect of renovascular hypertension on the expression of E-cad, N-cad, α-SMA, COL1A1, COL3A1 and HGF genes. Expression was detected using reverse transcription-PCR in the (A) liver, (B) heart and (C) kidneys with densitometric analysis was carried out for each gene for the sham and 2K1C groups. Values are expressed as the mean ± SEM for each group. \*P\<0.05 vs. respective sham; ^≠^P\<0.05 vs. contralateral 2K1C kidney. 2K1C, 2 kidney 1 clip; E-cad, E-cadherin; N-cad, N-cadherin; α-SMA, α-smooth muscle actin; COL1A1, collagen I; COL3A1, collagen III; HGF, hepatocyte growth factor; L, left; R, right.](MMR-20-05-4467-g01){#f2-mmr-20-05-4467}

###### 

Characteristics of the sham and 2K1C animals at the end of the experimental period.

  Parameter                        Sham (n=7)      2K1C (n=11)
  -------------------------------- --------------- --------------------------------------------------------------------------------------------------------------
  Body weight (g)                  360±29          382±22
  SBP (mmHg)                       148±4           203±9^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"}^
  Liver weight (g)                 9.24±0.36       8.74±0.19
  HWI (g/g)                        0.033±0.001     0.031±0.001
  Heart weight (g)                 1.005±0.091     1.391±0.097^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"}^
  CWI (g/g)                        0.0028±0.0001   0.0036±0.0001^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"}^
  Kidney weight (g)                                
    Right                          1.25±0.07       1.63±0.13^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"},[b](#tfn3-mmr-20-05-4467){ref-type="table-fn"}^
    Left                           1.28±0.11       0.93±0.07^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"}^
  KWI (g/g)                                        
    Right                          0.0035±0.0001   0.0042±0.0002^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"},[b](#tfn3-mmr-20-05-4467){ref-type="table-fn"}^
    Left                           0.0036±0.0001   0.0025±0.0002^[a](#tfn2-mmr-20-05-4467){ref-type="table-fn"}^
  Left kidney/right kidney ratio   1.018±0.04      0.599±0.06

Values are expressed as the mean ± SEM of three independent experiments. HWI, liver weight/body weight.

P\<0.05 vs. sham

P\<0.001 vs. 2K1C contralateral kidney. SBP, systolic blood pressure; HWI, hepatic weight index; CWI, cardiac weight index; KWI, kidney weight index; 2K1C, 2 kidney 1 clip.

###### 

Pro- and anti-inflammatory profile in 2K1C experimental model.

  A, Liver                                                               
  --------------------- ---------------- ----------------- ------------- ------------------------------------------------------------------------------------------------------------
  TGF-β1                                 353.6±42.9                      599.4±80.32^[a](#tfn5-mmr-20-05-4467){ref-type="table-fn"}^
  TNF-α                                  813.9±52                        1,114.5±99.61^[a](#tfn5-mmr-20-05-4467){ref-type="table-fn"}^
  IL-4                                   71.9±2                          69.0±4
  IL-10                                  782.9±83                        812.8±23
  IL-6                                   10,135.6±376                    9,475.9±253
                                                                         
  **B, Heart**                                                           
                                                                         
  **Protein (pg/ml)**                    **Sham (n=7)**                  **2K1C (n=11)**
                                                                         
  TGF-β1                                 89.05±4                         115.0±4^[a](#tfn5-mmr-20-05-4467){ref-type="table-fn"}^
  TNF-α                                  2,616.8±239                     2,247.4±95
  IL-4                                   20.9±1                          20.7±2
  IL-10                                  1,459.1±112                     1,468.8±143
  IL-6                                   3,728.9±80                      3,682.5±243
                                                                         
  **C, Kidney**                                                          
                                                                         
                        **Sham (n=7)**   **2K1C (n=11)**                 
                                                                         
  **Protein (pg/ml)**   **Right**        **Left**          **Right**     **Left**
                                                                         
  TGF-β1                318.0±31         438.6±40          396.6±44      631.2±2^[b](#tfn6-mmr-20-05-4467){ref-type="table-fn"},[c](#tfn7-mmr-20-05-4467){ref-type="table-fn"}^
  TNF-α                 3,138.7±56       3,103.6±279       3,337.8±264   3,175.5±447
  IL-4                  99.7±6           104.9±6           101.6±5       111.9±5
  IL-10                 1,854.4±64       1,844.8±100       1,859.8±98    1,812.4±66
  IL-6                  8,855.3±223      8,333.1±267       8,444.7±287   9,896.9±252^[b](#tfn6-mmr-20-05-4467){ref-type="table-fn"},[c](#tfn7-mmr-20-05-4467){ref-type="table-fn"}^

Values are expressed as the mean ± SEM of three independent experiments.

P\<0.05 vs. sham

P\<0.05 vs. contralateral 2K1C kidney

P\<0.05 vs. sham. 2K1C, 2 kidney 1 clip; TGF-β1, transforming growth factor-β1; TNF-α, tumor necrosis factor-α; IL, interleukin.

###### 

Parameters of oxidative stress.

  A, Liver                                                                                                                        
  ------------------------------ ---------------- ----------------- ------------------------------------------------------------- -------------------------------------------------------------
  TBARS (nmol/µg protein)                         0.022±0.004                                                                     0.023±0.008
  -SH groups (µmol/µg protein)                    0.770±0.460                                                                     1.053±0.273
                                                                                                                                  
  **B, Heart**                                                                                                                    
                                                                                                                                  
  **Analysis**                                    **Sham (n=7)**                                                                  **2K1C (n=11)**
                                                                                                                                  
  TBARS (nmol/µg protein)                         0.003±0.001                                                                     0.004±0.002
  -SH groups (µmol/µg protein)                    0.996±0.118                                                                     1.376±0.208^[a](#tfn9-mmr-20-05-4467){ref-type="table-fn"}^
                                                                                                                                  
  **C, Kidney**                                                                                                                   
                                                                                                                                  
                                 **Sham (n=7)**   **2K1C (n=11)**                                                                 
                                                                                                                                  
  **Analysis**                   **Right**        **Left**          **Right**                                                     **Left**
                                                                                                                                  
  TBARS (nmol/µg protein)        0.017±0.001      0.012±0.003       0.021±0.002^[a](#tfn9-mmr-20-05-4467){ref-type="table-fn"}^   0.022±0.004^[a](#tfn9-mmr-20-05-4467){ref-type="table-fn"}^
  -SH groups (µmol/µg protein)   0.972±0.196      0.881±0.094       1.045±0.025                                                   1.042±0.090

Values are expressed as the mean ± SEM of three independent experiments.

P=0.01 vs. sham. 2K1C, 2 kidney 1 clip; TBARS, thiobarbituric acid reactive substances.
